These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10212169)

  • 61. Endothelium-independent coronary vasodilatation in patients with single vessel ischemic heart disease and its relationship with coronary artery morphology.
    Manukov IH; Vladimirova-Kitova LG
    Folia Med (Plovdiv); 2007; 49(3-4):20-5. PubMed ID: 18504929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    J Am Coll Cardiol; 1990 Jul; 16(1):74-9. PubMed ID: 2358608
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Substance P potentiates the algogenic effects of intraarterial infusion of adenosine.
    Gaspardone A; Crea F; Tomai F; Iamele M; Crossman DC; Pappagallo M; Versaci F; Chiariello L; Gioffrè PA
    J Am Coll Cardiol; 1994 Aug; 24(2):477-82. PubMed ID: 7518480
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Case against routine use of glyceryl trinitrate before coronary angiography.
    Feldman RL; Peine CJ; Curry RC; Conti CR
    Br Heart J; 1978 Sep; 40(9):992-7. PubMed ID: 101222
    [No Abstract]   [Full Text] [Related]  

  • 65. Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man.
    Schaffalitzky De Muckadell OB; Aggestrup S; Stentoft P
    Scand J Gastroenterol; 1986 May; 21(4):498-502. PubMed ID: 2425412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An Account of a Substance obtained from a diseased Ovarium, with some Remarks on diseased Secretions of an analogous nature.
    Bostock J
    Med Chir Trans; 1819; 10(Pt 1):77-88. PubMed ID: 20895382
    [No Abstract]   [Full Text] [Related]  

  • 67. Cases of Wounded and Diseased Arteries.
    Travers B
    Lond Med Phys J; 1827 Apr; 2(10):327-334. PubMed ID: 30495533
    [No Abstract]   [Full Text] [Related]  

  • 68. Cases of Wounded and Diseased Arteries.
    Travers B
    Lond Med Phys J; 1827 Mar; 2(9):233-236. PubMed ID: 30495523
    [No Abstract]   [Full Text] [Related]  

  • 69. Cases of Diseased and Wounded Arteries.
    Travers B
    Lond Med Phys J; 1827 Jul; 3(13):25-30. PubMed ID: 30495462
    [No Abstract]   [Full Text] [Related]  

  • 70. L-Arginine-Nitric Oxide-Asymmetric Dimethylarginine Pathway and the Coronary Circulation: Translation of Basic Science Results to Clinical Practice.
    Cziráki A; Lenkey Z; Sulyok E; Szokodi I; Koller A
    Front Pharmacol; 2020; 11():569914. PubMed ID: 33117166
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure.
    Salles TA; dos Santos L; Barauna VG; Girardi AC
    Int J Mol Sci; 2015 Feb; 16(2):4226-49. PubMed ID: 25690036
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina.
    Tousoulis D; Xenakis C; Tentolouris C; Davies G; Antoniades C; Crake T; Stefanadis C
    Heart; 2005 Oct; 91(10):1319-23. PubMed ID: 16162626
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vasomotion and nitric oxide bioactivity in diseased coronary arteries.
    Tousoulis D; Davies GJ; Crake T; Toutouzas PC
    Heart; 2002 Apr; 87(4):320-1. PubMed ID: 11907000
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.
    Tousoulis D; Tentolouris C; Crake T; Katsimaglis G; Stefanadis C; Toutouzas P; Davies GJ
    Heart; 1999 May; 81(5):505-11. PubMed ID: 10212169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence of partially preserved endothelial dilator function in diseased coronary arteries.
    Tousoulis D; Tentolouris C; Crake T; Stefanadis C; Toutouzas P; Davies G
    Heart; 1999 Oct; 82(4):471-6. PubMed ID: 10490563
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.
    Tousoulis D; Davies GJ; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
    Heart; 2001 Sep; 86(3):296-301. PubMed ID: 11514482
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries.
    Tousoulis D; Davies GJ; Tentolouris C; Crake T; Katsimaglis G; Stefanadis C; Toutouzas P
    Am J Cardiol; 1998 Nov; 82(9):1110-3, A6. PubMed ID: 9817490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.
    Tousoulis D; Davies GJ; Tentolouris C; Crake T; Goumas G; Stefanadis C; Toutouzas P
    Heart; 2003 May; 89(5):531-4. PubMed ID: 12695458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Response of coronary arteries to nitrates, the EDRF-donor SIN-1, and calcium antagonists.
    Schulz W; Kober G
    Basic Res Cardiol; 1991; 86 Suppl 2():233-41. PubMed ID: 1953615
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.